Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...

Researchers have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder ...

The technology accurately detects the presence of ... Promising Cell Therapy Offers Hope for Relapsed or Refractory T-Cell Leukaemia Oct. 7, 2024 — Fratricide-resistant CD7 CAR-T therapy by NUS ...

THE word relapse carries a strong negative connotation. Many argue that it should now be referred to as reoccurrence due to its commonality and its role in progress and learning. It is often, ...

Scientists have supercharged CAR-T therapy, making it more powerful against elusive cancer cells that usually escape ...

Brazilian shoegaze” sounds like a subgenre that might be rattled off by a record collector in a High Fidelity-esque satire of ...

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the ...

Jia et al. used several mouse models to further explore the role of SPON2 expressed by NK cells in tumour control. In mice lacking Spon2 , HCC tumours grew larger and had reduced immune-cell ...

Nektar Therapeutics today reported financial results for the fourth quarter ended December 31, 2024. Cash and investments ...

Scientists have discovered that aspirin may prevent cancer metastasis by reducing TXA2 levels, which suppress T cells.